by FiveSenses | Dec 31, 2024 | News Release
Vancouver, BC, Canada, December 31st, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug... 
by Defence Therapeutics | Dec 20, 2024 | News Release
Vancouver, BC, Canada, December 20, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC) a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug...
Recent Comments